CANTON, N.C. (WLOS) — A 70-year-old local woman gets a diagnosis of terminal cancer with a short time to live. She’s speaking out on her approach to the news and has advice to others facing a similar ...

University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...

Integrated biomarker analyses confirm viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes ...

MiNK Therapeutics surged on tumor remission data for agenT-797, but financial risks and limited clinical proof remain. Learn ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

Compelling new preliminary data consistent with previously reported preclinical findings demonstrating certepetide’s potential ability to enhance the effectiveness of immunotherapy ...

The first half of 2025 has been topsy-turvy for Bristol Myers BMY. Shares of this biotech giant have lost 16.3% year to date compared with the industry ’s decline of 2.7%. The stock has also ...

If a gene is evolutionarily conserved, that shows it must be doing something important. Otherwise, nature would let it go.

No opening of the cranium, no cutting into the brain, no blood. Today's precise psychosurgery presents options for patients ...

Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATH ...

Let’s discuss a medical procedure that is currently making headlines. It is called ablation. Sportspeople are frequently ...